Andrey V. Grechko

6.3k citations

156 papers · 4.5k indexed · 5 hit papers · h-index 33

Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases 17
Cancer Research top 5%
Endocrinology, Diabetes and Metabolism top 2%
Biochemistry top 2%
Cardiology and Cardiovascular Medicine top 2%
- Heart Rate Variability and Autonomic Control 8
Molecular Biology
- Mitochondrial Function and Pathology 16
- Glycosylation and Glycoproteins Research 7
Surgery
- Lipoproteins and Cardiovascular Health 11
Neurology
- Traumatic Brain Injury and Neurovascular Disturbances 11
- Long-Term Effects of COVID-19 10
Epidemiology
- Healthcare Systems and Public Health 7

Co-authors: Alexander N. Orekhov Veronika A. Myasoedova Alexandra А. Melnichenko Dimitry A. Chistiakov Anastasia V. Poznyak Paolo Poggio Valentina Alfieri Ekaterina A. Ivanova
Cited by: Immunology Cancer Research Endocrinology, Diabetes and Metabolism
Journals: SHILAP Revista de lepidopterología (17 papers)International Journal of Molecular Sciences (15 papers)European Journal of Pharmacology (1 paper)
Partner nations: Russia Taiwan China

In The Last Decade

Andrey V. Grechko

132 papers receiving 4.5k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Frontiers in Cardiovascular Medicine
2020 International Journal of Molecular Sciences
2017 Annals of Medicine
2017 Oxidative Medicine and Cellular Longevity
2017 Journal of Molecular Medicine

Peers

Countries citing papers authored by Andrey V. Grechko

Since Specialization

Citations

This map shows the geographic impact of Andrey V. Grechko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey V. Grechko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey V. Grechko more than expected).

Fields of papers citing papers by Andrey V. Grechko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey V. Grechko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey V. Grechko. The network helps show where Andrey V. Grechko may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrey V. Grechko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrey V. Grechko Line = papers co-authored together Andrey V. Grechko links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of lithium chloride safety and toxicokinetics for injection in minipigs Сибирский научный медицинский журнал ·В. М. Косман,А. Romanenko,М. В. Карлина,Н. М. Фаустова,E. V. Mazukina,А. Н. Кузовлев,Andrey V. Grechko,R. A. Cherpakov,М. Н. Макарова,В. Г. Макаров	2025	0
2	Prognostic Modelling of Mortality in Chronic Critical Illness After Traumatic Brain Injury Journal of Clinical Medicine ·В. В. Лихванцев,D.L. Kolesov,Levan Berikashvili,Elizaveta Korolenok,M. Yа. Yadgarov,Kristina Kadantseva,Ivan Kuznetsov,Petr Polyakov,А. Н. Кузовлев,Andrey V. Grechko	2025	0
3	Interval Hypoxia-Hyperoxia Therapy as a Method of Treating Patients with Chronic Critical Illness Caused by Severe Brain Damage Anna A. Ilina,Marina V. Petrova,Andrey V. Grechko,Dmitrij Vladilenovich Ilin,Galina K. Spirina	2025	0
4	Assessment of Fluid Responsiveness via Central Venous Ultrasound Measurement: A Network Meta-Analysis Journal of Clinical Medicine ·Levan Berikashvili,Ivan Kuznetsov,M. Yа. Yadgarov,Pavel Ryzhkov,Petr Polyakov,Andrey Yavorovskiy,Alexey А. Yakovlev,Andrey V. Grechko,В. В. Лихванцев	2025	1
5	RICD: Russian Intensive Care Dataset SHILAP Revista de lepidopterología ·Andrey V. Grechko,M. Yа. Yadgarov,Alexey А. Yakovlev,Levan Berikashvili,А. Н. Кузовлев,P. A. Polyakov,Ivan Kuznetsov,В. В. Лихванцев	2024	5
6	Neuroprotective Effects of Krypton Inhalation on Photothrombotic Ischemic Stroke Biomedicines ·В. В. Антонова,Д. Н. Силачев,Egor Y. Plotnikov,Irina B. Pevzner,Elmira I. Yakupova,M. Pisarev,Е. А. Боева,З. И. Цоколаева,Maxim A. Lyubomudrov,И. В. Шумов,Andrey V. Grechko,О. А. Гребенчиков	2024	7
7	Early postoperative cognitive impairment after trauma surgery: a prospective cohort study Russian Journal of Anesthesiology and Reanimatology ·N. V. Ermokhina,А. Н. Кузовлев,Petr Polyakov,Roman Akchulpanov,Anastasiya Smirnova,Elizaveta A. Laricheva,E.N. Zemina,Denis V. Davydov,Andrey V. Grechko,A.Yu. Zavarzin	2024	0
8	Red cell Distribution Width index as prognostic marker of the course and outcome of pleural empyema developing after pneumonia: a prospective cohort study SHILAP Revista de lepidopterología ·Д. Л. Фетлам,А. Г. Чумаченко,А. В. Данилов,А. Н. Кузовлев,Andrey V. Grechko,В. М. Писарев	2024	0
9	Cell Surface Parameters for Accessing Neutrophil Activation Level with Atomic Force Microscopy Cells ·Oksana M. Tilinova,Vladimir Inozemtsev,Ekaterina Sherstyukova,Snezhanna Kandrashina,M. Pisarev,Andrey V. Grechko,N.V. Vorobjeva,В. А. Сергунова,Maxim Dokukin	2024	4
10	Asphyxial Circulatory Arrest with a Complex of Resuscitation Measures in an Experimental Model SHILAP Revista de lepidopterología ·Aleksey Dubensky,И. А. Рыжков,Konstantin Lapin,С. Н. Калабушев,Л. А. Варнакова,З. И. Цоколаева,В. Т. Долгих,Andrey V. Grechko	2024	0
11	Craniocerebral hypothermia in the acute period of ischemic stroke S S Korsakov Journal of Neurology and Psychiatry ·A. G. Gutsalyuk,Marina V. Petrova,K F Borozenets,О. А. Шевелев,Andrey V. Grechko,Elias M. Mengistu,L. M. Tsentsiper,D P Semerchev,Irina N. Kolbaskina,N T Mirilashvili	2023	1
12	Mechanochemical Synergism of Reactive Oxygen Species Influences on RBC Membrane International Journal of Molecular Sciences ·Е. К. Козлова,В. А. Сергунова,Ekaterina Sherstyukova,Andrey V. Grechko,Snezhanna Lyapunova,Vladimir Inozemtsev,А. П. Козлов,О. Е. Гудкова,А. М. Черныш	2023	7
13	Preclinical Orthostatic Abnormalities May Predict Early Increase in Vascular Stiffness in Different Age Groups: A Pilot Study Diagnostics ·Victor N. Dorogovtsev,D. S. Yankevich,A. E. Gaydashev,Andrey Martyushev-Poklad,Julia А. Podolskaya,Ilya V. Borisov,Andrey V. Grechko	2023	2
14	Adaptive Phage Therapy for the Prevention of Recurrent Nosocomial Pneumonia: Novel Protocol Description and Case Series Antibiotics ·Fedor Zurabov,Marina V. Petrova,Alexander Yu. Zurabov,Marina M. Gurkova,Petr Polyakov,Dmitriy Cheboksarov,Ekaterina Chernevskaya,Mikhail Yuryev,Valentina Popova,А. Н. Кузовлев,Alexey А. Yakovlev,Andrey V. Grechko	2023	4
15	Challenges of mitochondrial DNA editing in mammalian cells: focus on treatment of cardiovascular disease Vessel Plus ·Victoria A. Khotina,Mariam Bagheri Ekta,Mirza S. Baig,Wei‐Kai Wu,Andrey V. Grechko,Vasily N. Sukhorukov,Alexander N. Orekhov,Cameron Mccarthy Copy,Fangling Lan,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2022	3
16	Prospects of using adaptive phage therapy in the rehabilitation of post-COVID-19 patients Beloborodova Nv,Andrey V. Grechko,Alexander Yu. Zurabov,Fedor Zurabov,А. Н. Кузовлев,Marina V. Petrova,Ekaterina Chernevskaya,Alexey А. Yakovlev	2021	2
17	Sialidase Activity in Human Blood Serum Has a Distinct Seasonal Pattern: A Pilot Study Biology ·Victor Glanz,Dmitry Kashirskikh,Andrey V. Grechko,Shaw‐Fang Yet,Igor A. Sobenin,Alexander N. Orekhov	2020	5
18	Heteroplasmic Variants of Mitochondrial DNA in Atherosclerotic Lesions of Human Aortic Intima Biomolecules ·Igor A. Sobenin,Andrey V. Zhelankin,Zukhra B. Khasanova,Vasily V. Sinyov,Lyudmila V. Medvedeva,Maria O. Sagaidak,Vsevolod J. Makeev,Kira I. Kolmychkova,Anna Smirnova Henriques,Vasily N. Sukhorukov,Anton Y. Postnov,Andrey V. Grechko,Alexander N. Orekhov	2019	18
19	On the diagnosis and treatment of nosocomial tracheobronchitis in intensive care medicine Annals of critical care ·А. Н. Кузовлев,А. К. Шабанов,Andrey V. Grechko	2018	1
20	Mitochondrial genome variability: the effect on cellular functional activity Therapeutics and Clinical Risk Management ·Alexandrina S. Volobueva,Alexandra А. Melnichenko,Andrey V. Grechko,Alexander N. Orekhov	2018	8

About Andrey V. Grechko

Andrey V. Grechko is a scholar working on Critical Care and Intensive Care Medicine, Immunology and Neurology, having authored 156 papers that have together received 4.5k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (17 papers), Mitochondrial Function and Pathology (16 papers), Lipoproteins and Cardiovascular Health (11 papers), Traumatic Brain Injury and Neurovascular Disturbances (11 papers), Long-Term Effects of COVID-19 (10 papers), Heart Rate Variability and Autonomic Control (8 papers), Healthcare Systems and Public Health (7 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Immunology (1.1k citations), Cancer Research (531 citations) and Endocrinology, Diabetes and Metabolism (576 citations). Andrey V. Grechko has collaborated with scholars based in Russia, Taiwan and China. Frequent co-authors include Alexander N. Orekhov, Veronika A. Myasoedova, Alexandra А. Melnichenko, Alexander N. Orekhov, Dimitry A. Chistiakov, Anastasia V. Poznyak, Paolo Poggio, Valentina Alfieri, Ekaterina A. Ivanova and Т. П. Шкурат. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact